The SLRC chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SLRC chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SLRC stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View SLRC Detailed Price Forecast - CNN Money | View SLRC Detailed Summary - Google Finance | ||
View SLRC Detailed Summary - Yahoo! Finance | View SLRC Stock Research & Analysis - Zacks.com |
View SLRC Trends & Analysis - Trade-Ideas | View SLRC Major Holders - Barrons | ||
View SLRC Call Transcripts - NASDAQ | View SLRC Breaking News & Analysis - Seeking Alpha | ||
View SLRC Annual Report - CompanySpotlight.com | View SLRC OTC Short Report - OTCShortReport.com | ||
View SLRC Fundamentals - TradeKing | View SLRC SEC Filings - Bar Chart | ||
View Historical Prices for SLRC - The WSJ | View Performance/Total Return for SLRC - Morningstar | ||
View the Analyst Estimates for SLRC - MarketWatch | View the Earnings History for SLRC - CNBC | ||
View the SLRC Earnings - StockMarketWatch | View SLRC Buy or Sell Recommendations - MacroAxis | ||
View the SLRC Bullish Patterns - American Bulls | View SLRC Short Pain Metrics - ShortPainBot.com |
View SLRC Stock Mentions - StockTwits | View SLRC Stock Mentions - PennyStockTweets | ||
View SLRC Stock Mentions - Twitter | View SLRC Investment Forum News - Investor Hub | ||
View SLRC Stock Mentions - Yahoo! Message Board | View SLRC Stock Mentions - Seeking Alpha |
View Insider Transactions for SLRC - SECform4.com | View Insider Transactions for SLRC - Insider Cow | ||
View SLRC Major Holdings Summary - CNBC | View Insider Disclosure for SLRC - OTC Markets | ||
View Insider Transactions for SLRC - Yahoo! Finance | View Institutional Holdings for SLRC - NASDAQ |
View SLRC Stock Insight & Charts - FinViz.com | View SLRC Investment Charts - StockCharts.com | ||
View SLRC Stock Overview & Charts - BarChart | View SLRC User Generated Charts - Trading View |
SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended March 31, 2024
Posted on Monday April 01, 2024
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- SLR Investment Corp. (the “Company”) (NASDAQ: SLRC) today announced that it will release its financial results for the quarter ended March 31, 2024 on Wednesday, May 8, 2024 after the close of the financial markets. The Company will host an earnings conference call and audio webcast at 10:00 a.m. (Eastern Time) on Thursday, May 9, 2024. All interested parties may participate in the conference call by dialing (800) 445-7795 approximately 5-10 minutes p
SLR Investment Corp Reports Steady NAV and Record Originations in Q4 2023
Posted on Tuesday February 27, 2024
Net Investment Income Grows as Company Capitalizes on Favorable Investment Environment
SLR Investment Corp. Announces Quarter and Year Ended December 31, 2023 Financial Results
Posted on Tuesday February 27, 2024
Net Investment Income of $0.44 Per Share for Q4 2023; Declared Quarterly Distribution of $0.41 Per Share; Stable NAV and Strong Portfolio Credit Quality NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC) (the “Company”, “SLRC”, “we”, or “our”) today reported net investment income of $23.9 million, or $0.44 per share, for the fourth quarter of 2023. As of December 31, 2023, net asset value (NAV) was $18.09 per share, compared to $18.06 as of September 30, 2023. In the
SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System
Posted on Thursday February 01, 2024
CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, today announced that it has secured $85 million in financing including $25 million in Series D-1 insider equity and a $60 million debt facility. The equity financing was led by Revelation Partners, SPR’s lead investor of the Series D equity financing, and incumbent investors, RC Capital and Mutual C